Sec. 6094. Technical expert panel on reducing surgical setting opioid use; Data collection on perioperative opioid use
432 words·~2 min read·
/bill/115/hr/6/eah/section-6094A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Not later than 6 months after the date of the enactment of this Act, the Secretary of Health and Human Services shall convene a technical expert panel, including medical and surgical specialty societies and hospital organizations, to provide recommendations on reducing opioid use in the inpatient and outpatient surgical settings and on best practices for pain management, including with respect to the following: Approaches that limit patient exposure to opioids during the perioperative period, including pre-surgical and post-surgical injections, and that identify such patients at risk of opioid use disorder pre-operation.
Shared decision making with patients and families on pain management, including a review of payment to ensure payment under the Medicare program under title XVIII of the Social Security Act accounts for time spent on shared decision making. Education on the safe use, storage, and disposal of opioids. Prevention of opioid misuse and abuse after discharge. Development of a clinical algorithm to identify and treat at-risk, opiate-tolerant patients and reduce reliance on opioids for acute pain during the perioperative period.
Not later than 1 year after the date of the enactment of this Act, the Secretary shall submit to Congress and make public a report containing the recommendations developed under paragraph
(1)and an action plan for broader implementation of pain management protocols that limit the use of opioids in the perioperative setting and upon discharge from such setting. Not later than 1 year after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report that contains the following: The diagnosis-related group codes identified by the Secretary as having the highest volume of surgeries. With respect to each of such diagnosis-related group codes so identified, a determination by the Secretary of the data that is both available and reported on opioid use following such surgeries, such as with respect to— surgical volumes, practices, and opioid prescribing patterns; opioid consumption, including— perioperative days of therapy; average daily dose at the hospital, including dosage greater than 90 milligram morphine equivalent; post-discharge prescriptions and other combination drugs that are used before intervention and after intervention; quantity and duration of opioid prescription at discharge; and quantity consumed and number of refills; regional anesthesia and analgesia practices, including pre-surgical and post-surgical injections; naloxone reversal; post-operative respiratory failure; information about storage and disposal; and such other information as the Secretary may specify. Recommendations for improving data collection on perioperative opioid use, including an analysis to identify and reduce barriers to collecting, reporting, and analyzing the data described in paragraph (2), including barriers related to technological availability.